ERNA vs JPM · P/E 0.0, rev $582.0K vs P/E 14, rev $182.45B
Eterna Therapeutics Inc (ERNA) versus JPMorgan Chase & Co (JPM) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
JPMorgan Chase & Co (JPM) is a banks - diversified company listed on US. It is led by Jamie Dimon.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported JPM revenue for 2025-12-31 was $182.45B. Net income was $57.05B. Revenue was up 2.8% from 2024-12-31 to 2025-12-31. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. JPM currently screens at market cap $805.69B and trailing P/E 14.2.
Not investment advice. Open the ERNA and JPM stock pages for the full models.
Not investment advice.